Join the Network

Overview

ALZ-NET is seeking applications for health systems, health care providers and imaging facilities to participate in the Network. Please review instructions for becoming a participating site or imaging facility and relevant qualifications prior to beginning your registration. 

Join the Network

Begin registration

1. Review the ALZ-NET Protocol Synopsis and the Imaging Facility Participation Overview (if applicable). 
2. Click the Begin Registration button above to access the ALZ-NET Portal. 
3. Log in to the ALZ-NET Portal with your ACR ID or Create your ACR ID.
4. Select "Register My Site" or "Register My Facility."
5. Submit the 10-minute Registration Form. 
6. The ALZ-NET Operations Team will review your application.
7. Invited sites and imaging facilities will receive an email with essential start-up documents and additional instructions. 

For additional information on the ALZ-NET Portal, please review the following trainings: 

• ALZ-NET Portal Training Guide for Site Staff 
• ALZ-NET Portal Training Guide for Imaging Facility Staff 

Site Qualifications

Dementia Practice

Data collected will describe the multi-disciplinary dementia care team, patient population and enrollment feasibility such as: 

• Access to:
  • Accredited and appropriate radiological services for diagnostic and safety brain imaging
  • Infusion services
  • Emergency services
  • Standard cognitive, behavioral, and functional assessments used in dementia care
• Race and ethnicity percentages of patient population
• Estimated enrollment capabilities based on the ALZ-NET eligibility criteria

Imaging Facility

• Perform Alzheimer's disease related brain imaging (Note: if MRI, must utilize an accredited 3T and/or 1.5T magnet MRI scanner.) 
• Be accredited by one of the following for modalities applicable to Alzheimer's imaging:
  • Medicare-approved hospital-accrediting body (e.g., Joint Commission, DNV)
  • American College of Radiology (ACR)
  • Intersocietal Accreditation Commission (IAC)
  • RadSite
• Be able to upload DICOM images via TRIAD or ACR Connect. 

Site Investigator Qualifications

• Must hold credentials that authorize prescription of novel FDA-approved therapies.
  • Novel FDA-approved therapies for AD are drugs that have received approval as treatments for Alzheimer's disease (AD) from the U.S. Food and Drug Administration since 2021. 
  • Site Investigator may be a physician, physician assistant, or nurse practitioner.
• All site investigators must have the appropriate education and ability for contact time for evaluation and care of adults with acquired cognitive impairment or dementia.